Brought to you by:
F/BEVAR has high technical success and low mortality in chronic post-dissection TAAA
Fenestrated/branched endovascular aneurysm repair (F/BEVAR) is associated with high technical success and low mortality in patients with chronic post-dissection thoracoabdominal aortic aneurysm (PD-TAAA). This conclusion was presented by Mohamed A. Abdelhalim, MBChB, a PhD research fellow at St Thomas’ Hospital,…
Low rate of new white lesions detected after TCAR using diffusion-weighted MRI
New white lesions are not a common occurrence in patients who have undergone transcarotid artery revascularization (TCAR), a study in which patients were assessed post-procedurally using diffusion-weighted magnetic resonance imaging (DW-MRI), has found. This was the finding delivered by Raghu…
Medicare cuts: ‘It is crucially important we stay engaged in the process’
Society for Vascular Surgery (SVS) members deemed payment and reimbursement among the top advocacy priorities for 2022. A session Wednesday at VAM informed attendees about Medicare payment issues and relayed information on the past, what’s going on in the present…
Trust, transportation, insurance hamper ‘quality vascular surgery care for all,’ Crawford Forum hears
An absence of patient trust in their doctors and hospital systems yesterday morning emerged as a key talking point amid a comprehensive deep dive into some of the problems vascular surgeons tackle in their efforts to broaden access to quality…
Researchers report higher three-year amputation and reintervention rates in Black and Hispanic CLTI patients
In a study of over 7,000 chronic limb-threatening ischemia (CLTI) patients, researchers found that Black and Hispanic patients had higher three-year amputation and reintervention rates; survival, however, was higher among Black patients and similar between Hispanic and White patients. Aderike…
Silk Road to evaluate TCAR in standard surgical risk patients with ROADSTER 3 study
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularization (TCAR) system in the treatment of standard surgical risk patients with carotid artery disease. The ROADSTER 3 study will fulfill the US Food and Drug Administration’s…
Regional society leaders look forward to VAM and beyond
We asked the presidents of all five major regional vascular societies in the United States for an update on the latest goings-on in their organizations, how their presidencies are progressing, and what papers and talks they are looking out for…
Missing something? View VAM 2022 on-demand sessions
Pre-recorded videos from Vascular Annual Meeting (VAM) 2022 sessions are now available on-demand. If videos were submitted by faculty in advance, they will be available right after the session concludes. Access them now in the mobile app or in the…
A handy guide for VAM attendees: 2022’s Online Planner
The Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) 2022 Online Planner is an invaluable companion at the event in Boston’s Hynes Convention Center. Users can easily search for meeting information via laptop, tablet or phone. Visit the VAM…
Vascular Live: Variety of vascular concerns on the slate
Be sure to save time for the Vascular Live theater-in-the-round presentations in the Exhibit Hall at the 2022 Vascular Annual Meeting (VAM) in Boston. These sessions, on a variety of topics of importance to vascular surgeons, frequently play to big…